AMPOL LIMITED (ALD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALD - AMPOL LIMITED

FNArena Sector : Consumer Products & Services
Year End: December
GICS Industry Group : NONE
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Ampol (previously branded as Caltex Australia) is an Australian petroleum company first incorporated in 1936 in New South Wales. The company first listed on the ASX in 1948.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$28.06

05 Dec
2022

-0.090

OPEN

$28.15

-0.32%

HIGH

$28.29

560,703

LOW

$27.91

TARGET
$34.754 23.9% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
MMM . IVC . WES . PFP .
FNARENA'S MARKET CONSENSUS FORECASTS
ALD: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx 234.2 340.9 xxx
DPS (cps) xxx 93.0 209.0 xxx
EPS Growth xxx N/A 45.5% xxx
DPS Growth xxx 93.8% 100.0% xxx
PE Ratio xxx N/A 8.2 xxx
Dividend Yield xxx N/A 7.4% xxx
Div Pay Ratio(%) xxx 39.7% 61.3% xxx

Dividend yield today if purchased 3 years ago: 2.69%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.30

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 02/09 - ex-div 120c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx234.2
DPS All xxxxxxxxxxxxxxx93.0
Sales/Revenue xxxxxxxxxxxxxxx21,420.9 M
Book Value Per Share xxxxxxxxxxxxxxx1,290.3
Net Operating Cash Flow xxxxxxxxxxxxxxx634.6 M
Net Profit Margin xxxxxxxxxxxxxxx2.61 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx18.59 %
Return on Invested Capital xxxxxxxxxxxxxxx11.56 %
Return on Assets xxxxxxxxxxxxxxx6.93 %
Return on Equity xxxxxxxxxxxxxxx18.59 %
Return on Total Capital xxxxxxxxxxxxxxx12.93 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx149.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

26/10/2022

1

Upgrade to Outperform from Neutral

$30.49

8.66%

Credit Suisse believes Ampol's share price has been unfairly marked-down following 3Q results and upgrades its rating to Outperform from Neutral.

Earnings (EBIT) came in at $266m compared to the analyst's forecast for $338m, due to underperformance in Fuels and Infrastructure on a number of trading-related factors and adverse movements in freight.

The target price falls to $30.49 from $31.93 after the broker downgrades FY22 and FY23 EPS estimates by -6.2% and -7.6%, respectively.

FORECAST
Credit Suisse forecasts a full year FY22 dividend of 211.00 cents and EPS of 341.00 cents.
Credit Suisse forecasts a full year FY23 dividend of 162.00 cents and EPS of 268.00 cents.

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxxxxxx xx xxxxx-xxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

ALD STOCK CHART